In this issue: Diabetes researchers oppose the regulation of islet transplantati...
Illumina aims to finalise the terms of this divestiture by the end of the second...
The Novo Nordisk Foundation has invested Dkr1.8bn in the initiative to develop v...
Following US and UK approvals, the EMA’s CHMP has recommended conditional approv...
Biocytogen Pharmaceuticals and Ona Therapeutics signed an antibody agreement to ...
“One of the reasons I retired was because I was expected to perform these annual...
What took so long for the World Health Organization to recognize the devastating...
Illumina, the leading maker of DNA sequencing machines, said it would divest Gra...
Vertical integration, hospital mergers, and important small deals defined the he...
The US government is set to receive an additional 230,000 doses of RSV injection...
Reneo’s mavodelpar failed to meet its endpoints in the Phase III trial in primar...
Teva Pharmaceutical has signed a licence agreement with Biolojic Design for the ...
The US FDA granted approval for US WorldMeds’ iwilfin for use as an oral mainten...
The Inflation Reduction Act targets annual savings of $25m by 2031 by requiring ...
This is the second FDA approval for MSD’s HIF-2α inhibitor following a 2021 appr...
Biovac has received an investment and advisory package from the IFC to support v...
